Dorothee Viemann Selected Research

Dorothee Viemann Research Topics

Disease

10	Infections 01/2022 - 10/2009
8	Sepsis (Septicemia) 12/2020 - 10/2005
4	Human Influenza (Influenza) 01/2022 - 10/2009
4	Inflammation (Inflammations) 01/2015 - 12/2007
2	Neonatal Sepsis 12/2020 - 10/2005
2	Septic Shock (Toxic Shock Syndrome) 01/2017 - 12/2014
2	Cytokine Release Syndrome 01/2014 - 10/2009
2	Pneumonia (Pneumonitis) 02/2010 - 05/2007
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 12/2007 - 09/2003
1	Viral Pneumonia 01/2023
1	Lung Injury 01/2023
1	COVID-19 01/2022
1	Fibrosarcoma 01/2022
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2022
1	Neoplasms (Cancer) 01/2022
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2022
1	Bone Marrow Failure Disorders 01/2022
1	Body Weight (Weight, Body) 12/2020
1	Obesity 12/2020
1	Dysbiosis 11/2019
1	Premature Birth (Birth, Premature) 01/2017
1	Birth Weight (Birth Weights) 01/2016
1	Burns 12/2014
1	Multiple Trauma (Multiple Injuries) 12/2014
1	Wounds and Injuries (Trauma) 12/2014
1	Endotoxemia 06/2013
1	Vasculitis (Vasculitides) 05/2012
1	Necrosis 05/2012
1	Vascular Remodeling 04/2010
1	Bone Fractures (Bone Fracture) 02/2010
1	Job Syndrome (Hyper-IgE Syndrome) 02/2010
1	Exanthema (Rash) 02/2010
1	Influenza in Birds (Avian Flu) 10/2009
1	Virus Diseases (Viral Diseases) 11/2008
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 12/2007
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 05/2007
1	Acute Lung Injury 05/2007
1	Hypoxia (Hypoxemia) 03/2007
1	Contact Dermatitis (Eczema, Contact) 03/2007
1	Hypersensitivity (Allergy) 03/2007
1	Communicable Diseases (Infectious Diseases) 10/2005
1	Systemic Vasculitis 04/2005
1	Autoimmune Diseases (Autoimmune Disease) 09/2003

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2003
6	CytokinesIBA 01/2022 - 10/2009
4	AlarminsIBA 01/2017 - 06/2013
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2019
3	Receptor for Advanced Glycation End ProductsIBA 01/2015 - 05/2007
3	S100A12 ProteinIBA 06/2013 - 05/2007
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2016 - 10/2010
2	Antiviral Agents (Antivirals)IBA 01/2014 - 01/2011
2	LigandsIBA 06/2013 - 12/2007
2	NF-kappa B (NF-kB)IBA 10/2009 - 03/2007
2	Pattern Recognition ReceptorsIBA 12/2007 - 10/2005
1	ProcalcitoninIBA 01/2023
1	2- (2- chloro- 4- iodophenylamino)- N- 3,4- difluorobenzoic acidIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 12/2020
1	S100 Proteins (S 100 Protein)IBA 12/2020
1	Messenger RNA (mRNA)IBA 12/2020
1	16S Ribosomal RNAIBA 11/2019
1	ChromatinIBA 12/2014
1	EndotoxinsIBA 12/2014
1	Toll-Like Receptor 4IBA 12/2014
1	4- (4- fluorophenyl)- 2- (4- hydroxyphenyl)- 5- (4- pyridyl)imidazoleIBA 01/2014
1	p38 Mitogen-Activated Protein KinasesIBA 01/2014
1	Viral ProteinsIBA 07/2012
1	InflammasomesIBA 07/2012
1	GlucocorticoidsIBA 05/2012
1	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 01/2011
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 04/2010
1	Transcription Factors (Transcription Factor)IBA 04/2010
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2010
1	Immunoglobulin E (IgE)IBA 02/2010
1	Interferon Type IIBA 11/2008
1	EnzymesIBA 12/2007
1	ImmunosorbentsIBA 12/2007
1	AllergensIBA 03/2007
1	NickelIBA 03/2007
1	C-Reactive ProteinIBA 10/2005
1	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2005
1	Interleukin-8 (Interleukin 8)IBA 10/2005
1	Interleukin-6 (Interleukin 6)IBA 10/2005

Therapy/Procedure

1	Immunotherapy 12/2021
1	Cesarean Section (Caesarean Section) 01/2017
1	Therapeutics 05/2012